The objective of this prospective randomized single-center study was to compare primary and secondary patency rates, number of percutaneous transluminal angioplasty (PTA) interventions and cost-effectiveness among PTA, deployment of a stent, or a stent graft in the treatment of failing arteriovenous dialysis grafts (AVG) due to restenosis in the venous anastomosis or the outflow vein. Altogether 60 patients with failing AVG and restenosis in the venous anastomosis or the outflow vein were randomly assigned to either PTA, placement of a stent (E-Luminexx®) or stent graft (Fluency Plus®). After the procedure, patients with stent or stent graft received dual antiplatelet therapy for the next three months. Follow-up angiography was scheduled at 3, 6, and 12 months unless requested earlier due to suspected stenosis or malfunction of the access. Subsequently, angiography was performed only if requested by the clinician. During a median follow-up of 22.4 (IQR=5.7) months patients with PTA, stent, or stent graft required 3.1±1.7, 2.5±1.7, or 1.7±2.1 (P=0.031) secondary PTA interventions. The primary patency rates were 0, 18 and 65% at 12 months and 0, 18 and 37% at 24 months in the PTA, stent, and stent graft group respectively (P<0.0001). The cost of the procedures in the first two years was €7,900±€3,300 in the PTA group, €8,500±€4,500 in the stent group, and €7,500±€6,200 in the stent graft group (P=0.45). We conclude that the treatment of failing dialysis vascular access by the deployment of a stent graft significantly improves its primary patency rates and decreases the number of secondary PTA interventions; however, the reduction in costs for maintaining AVG patency is not significant.

2nd Department of Surgery 1st Faculty of Medicine Charles University and General University Hospital Prague Prague 12808 Czech Republic

3rd Department of Internal Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Prague 12808 Czech Republic

Department of Radiology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague 12808 Czech Republic

See more in PubMed

Vascular Access Work Group Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl 1):S248–S273. doi: 10.1053/j.ajkd.2006.04.040. PubMed DOI

El Kassem M, Alghamdi I, Vazquez-Padron RI, Asif A, Lenz O, Sanjar T, Fayad F, Salman L. The role of endovascular stents in dialysis access maintenance. Adv Chronic Kidney Dis. 2015;22:453–458. doi: 10.1053/j.ackd.2015.02.001. PubMed DOI PMC

MacRae JM, Dipchand C, Oliver M, Moist L, Lok C, Clark E, Hiremath S, Kappel J, Kiaii M, Luscombe R, et al. Arteriovenous access failure, stenosis, and thrombosis. Can J Kidney Health Dis. 2016;3:1–11. doi: 10.1177/2054358116669126. PubMed DOI PMC

Bittl JA. Catheter interventions for hemodialysis fistulas and grafts. JACC Cardiovasc Interv. 2010;3:1–11. doi: 10.1016/j.jcin.2009.10.021. PubMed DOI

Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int. 1992;42:1390–1397. doi: 10.1038/ki.1992.431. PubMed DOI

Chan MR, Bedi S, Sanchez RJ, Young HN, Becker YT, Kellerman PS, Yevzlin AS. Stent placement versus angioplasty improves patency of arteriovenous grafts and blood flow of arteriovenous fistulae. Clin J Am Soc Nephrol. 2008;3:699–705. doi: 10.2215/CJN.04831107. PubMed DOI PMC

Fu N, Joachim E, Yevzlin AS, Shin JI, Astor BC, Chan MR. A meta-analysis of stent placement vs. angioplasty for dialysis vascular access stenosis. Semin Dial. 2015;28:311–317. doi: 10.1111/sdi.12314. PubMed DOI

Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, Berman S, McLennan G, Trimmer C, Ross J, Vesely T. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362:494–503. doi: 10.1056/NEJMoa0902045. PubMed DOI

Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. J Vasc Surg. 2016;64:1400–1410.e1. doi: 10.1016/j.jvs.2016.04.035. PubMed DOI

Salman L, Asif A. Stent graft for nephrologists: Concerns and consensus. Clin J Am Soc Nephrol. 2010;5:1347–1352. doi: 10.2215/CJN.02380310. PubMed DOI

Kudlicka J, Kavan J, Tuka V, Malik J. More precise diagnosis of access stenosis: Ultrasonography versus angiography. J Vasc Access. 2012;13:310–314. doi: 10.5301/jva.5000047. PubMed DOI

Bittl JA, Feldman RL. Prospective assessment of hemodialysis access patency after percutaneous intervention: Cox proportional hazards analysis. Catheter Cardiovasc Interv. 2005;66:309–315. doi: 10.1002/ccd.20519. PubMed DOI

Bittl JA, Cohen DJ, Seek MM, Feldman RL. Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis-access thrombosis. Catheter Cardiovasc Interv. 2010;75:14–21. PubMed

Martin C, III, Pillai R. Dialysis access anatomy and interventions: A primer. Semin Interv Radiol. 2016;33:52–55. doi: 10.1055/s-0036-1578811. PubMed DOI PMC

Tessitore N, Mansueto G, Bedogna V, Lipari G, Poli A, Gammaro L, Baggio E, Morana G, Loschiavo C, Laudon A, et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. J Am Soc Nephrol. 2003;14:1623–1627. doi: 10.1097/01.ASN.0000069218.31647.39. PubMed DOI

Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW, DeYoung WJ, Blythe L, Stitt LW, Lindsay RM. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol. 2003;14:2645–2653. doi: 10.1097/01.ASN.0000089562.98338.60. PubMed DOI

Peden EK. Role of stent grafts for the treatment of failing hemodialysis accesses. Semin Vasc Surg. 2011;24:119–127. doi: 10.1053/j.semvascsurg.2011.05.011. PubMed DOI

Planken RN, van Kesteren F, Reekers JA. Treatment of hemodialysis vascular access arteriovenous graft failure by percutaneous intervention. J Vasc Access. 2014;15(Suppl 7):S114–S119. doi: 10.5301/jva.5000234. PubMed DOI

Rajan DK. Balloon angioplasty for low-flow access. J Vasc Access. 2015;16(Suppl 9):S66–S67. doi: 10.5301/jva.5000344. PubMed DOI

Boitet A, Massy ZA, Goeau-Brissonniere O, Javerliat I, Coggia M, Coscas R. Drug-coated balloon angioplasty for dialysis access fistula stenosis. Semin Vasc Surg. 2016;29:178–185. doi: 10.1053/j.semvascsurg.2016.08.002. PubMed DOI

Hoffer EK, Sultan S, Herskowitz MM, Daniels ID, Sclafani SJ. Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. J Vasc Interv Radiol. 1997;8:965–973. doi: 10.1016/S1051-0443(97)70695-X. PubMed DOI

McLennan G. Stent and stent-graft use in arteriovenous dialysis access. Semin Interv Radiol. 2016;33:10–14. doi: 10.1055/s-0036-1571806. PubMed DOI PMC

Yevzlin A, Asif A. Stent placement in hemodialysis access: Historical lessons, the state of the art and future directions. Clin J Am Soc Nephrol. 2009;4:996–1008. doi: 10.2215/CJN.04040808. PubMed DOI

Carmona J, Rits Y, Jones B, Dowers L, Bednarski D, Rubin JR. Patency of the Viabahn stent graft for the treatment of outflow stenosis in hemodialysis grafts. Am J Surg. 2016;211:551–554. doi: 10.1016/j.amjsurg.2015.12.006. PubMed DOI

Schmelter C, Raab U, Lazarus F, Ruppert V, Vorwerk D. Outcomes of AV fistulas and AV grafts after interventional stent-graft deployment in haemodialysis patients. Cardiovasc Intervent Radiol. 2015;38:878–886. doi: 10.1007/s00270-014-1018-7. PubMed DOI

Hiremath S, Holden RM, Fergusson D, Zimmerman DL. Antiplatelet medications in hemodialysis patients: A systematic review of bleeding rates. Clin J Am Soc Nephrol. 2009;4:1347–1355. doi: 10.2215/CJN.00810209. PubMed DOI PMC

Coleman CI, Tuttle LA, Teevan C, Baker WL, White CM, Reinhart KM. Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: A meta analysis. Int J Clin Pract. 2010;64:1239–1244. doi: 10.1111/j.1742-1241.2009.02329.x. PubMed DOI

Neuen BL, Gunnarsson R, Webster AC, Baer RA, Golledge J, Mantha ML. Predictors of patency after balloon angioplasty in hemodialysis fistulas: A systematic review. J Vasc Interv Radiol. 2014;25:917–924. doi: 10.1016/j.jvir.2014.02.010. PubMed DOI

Chan MG, Miller FJ, Valji K, Bansal A, Kuo MD. Evaluating patency rates of an ultralow-porosity expanded polytetrafluoroethylene covered stent in the treatment of venous stenosis in arteriovenous dialysis circuits. J Vasc Interv Radiol. 2014;25:183–189. doi: 10.1016/j.jvir.2013.10.006. PubMed DOI

Dolmatch B, Hogan A, Ferko N. An economic analysis of stent grafts for treatment of vascular access stenosis: Point-of-care and medicare perspectives in the United States. J Vasc Interv Radiol. 2018;29:765–773.e2. doi: 10.1016/j.jvir.2018.01.777. PubMed DOI

Angioplasty of Dysfunctional Dialysis Fistula or Graft with Resveratrol-Excipient and Paclitaxel-Coated Balloon Improves Primary Patency Rates Compared to Plain Angioplasty Alone